David joined Triplet Therapeutics, Inc. as Senior Medical Director, Neurology in April 2021. Dr. Jackson will perform a key role in providing medical expertise and direction in global clinical drug development strategy and planning with a focus on neurodegenerative repeat expansion disorders. In previous roles, David has extensive clinical research experience in multiple therapeutic areas including Neuro-Oncology, Neuro-Immunology, Neuropeptide Signaling, and Neurodegenerative Diseases.
David is an advocate of translational medicine and a regular keynote speaker at multiple global conferences advocating for the increased use of virtual clinical trials utilizing digital technologies to reduce cycle time in clinical drug development. David earned his MD from All Saints University School of Medicine and an MBA from the University of Memphis.